Categories
Connect with us on LinkedIn
8 Data Types to Collect Remotely
Decentralized clinical trials (DCT) are collecting many kinds of data remotely, and this data is only expected to...
What Is eConsent in Clinical Trials?
eConsent accelerates enrollment, increases retention, and reduces site burden. Find out why it’s the way of the future...
Developing an Infrastructure for Patient-Centric Decentralized Trials
Castor and Lightship discuss the infrastructure needs for providing the best patient experience and ensuring data integrity in...
Three Ways Remote eConsent Improves Trial Efficiency
eConsent accelerates enrollment, increases retention, and reduces site burden. Learn why it’s the way of the future for...
Video Conferencing for Remote eConsent: 5 Reasons to Make the Switch
Castor is using video conferencing to meet participant needs and lower site burden in clinical trials. Find 5...
How to Prepare an IRB Submission for a Remote eConsent Study
If you are planning on using eConsent in a trial, you’ll need to include it in your IRB...
Understanding the Nuances of Informed Consent in Clinical Trials
Informed consent is a critical aspect of clinical trials. But what criteria must be met? And is there...
The True Meaning & Value of eConsent in Clinical Trials
The future of informed consent is digital. Learn about the benefits, the process, the regulatory landscape, and the...
Castor Provides Continued Support to the World Health Organization, Powering the World’s Largest Adaptive COVID-19 Trial
Castor announced continued support for the WHO Solidarity trial, the world's largest adaptive COVID-19 trial.
Making a Real-World Difference for Patients & Clinical Trials
Learn why myTomorrows utilizes Castor to monitor treatment and assess benefit/risk its users, connecting patients with expanded trial...
Castor Inks Big Pharma Deal As Decentralized Trials Business Continues to Show Exponential Growth
Hoboken, New Jersey: March 10, 2021: Castor, a leading provider of clinical trial technology, today announced the signing...
Why Remote Consent Is the New Normal in 2021
COVID-19 changed the conversation around enrollment and recruitment for clinical trials. Learn how eConsent is helping researchers do...
Castor Launches Scalable Decentralized Trial Platform After 383% Commercial Growth
Hoboken, New Jersey: December 17, 2020: Castor, a leading provider of clinical trial technology, today announced the launch...
Top 4 eConsent Questions from Clinical Researchers
In September 2020, Castor CEO Derk Arts, MD, Ph.D., led a webinar on electronic informed consent (eConsent) challenges...
Castor Expands Advisory Board to Support US Growth of Decentralized Clinical Trial Platform
Industry veterans from leading life sciences companies including Johnson & Johnson, Biogen, and Medtronic, will support the Company’s...
Decentralized Trial Tech Strategy In Three Steps
Though technologies that support decentralized clinical trials (DCT) have been readily available for years, meaningful industry adoption has...
Common shortcomings of clinical research data for PMCF
The following is an excerpt from our free whitepaper ‘Satisfying PMCF requirements by utilizing IIS data’. Click here...
Castor is now live in Australia!
To support our growing customer base in the APAC region, we established new hosting in Australia. By allowing...
Connect with us on LinkedIn
